TransMedics Group (TMDX) Competitors

TransMedics Group (NASDAQ:TMDX) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Which has stronger valuation & earnings, TMDX or ZBH?

Zimmer Biomet has higher revenue and earnings than TransMedics Group. Zimmer Biomet is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$441.54M	9.86	$35.46M	$1.36	94.65
Zimmer Biomet	$7.68B	2.41	$903.70M	$4.52	20.72

Is TMDX or ZBH more profitable?

Zimmer Biomet has a net margin of 11.86% compared to TransMedics Group's net margin of 10.03%. TransMedics Group's return on equity of 21.88% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	10.03%	21.88%	6.15%
Zimmer Biomet	11.86%	12.73%	7.34%

Do insiders & institutionals hold more shares of TMDX or ZBH?

99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by company insiders. Comparatively, 1.4% of Zimmer Biomet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media favor TMDX or ZBH?

In the previous week, Zimmer Biomet had 12 more articles in the media than TransMedics Group. MarketBeat recorded 21 mentions for Zimmer Biomet and 9 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 1.21 beat Zimmer Biomet's score of 0.79 indicating that TransMedics Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	13 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate TMDX or ZBH?

TransMedics Group presently has a consensus target price of $127.33, suggesting a potential downside of 1.08%. Zimmer Biomet has a consensus target price of $111.33, suggesting a potential upside of 18.86%. Given Zimmer Biomet's higher probable upside, analysts plainly believe Zimmer Biomet is more favorable than TransMedics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80
Zimmer Biomet	2 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.30

Which has more risk & volatility, TMDX or ZBH?

TransMedics Group has a beta of 2.06, suggesting that its stock price is 106% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

Summary

TransMedics Group beats Zimmer Biomet on 9 of the 17 factors compared between the two stocks.